salmeterol/fluticasone neutec 50 mikrog / 100 mikrog
neutec inhaler ireland limited - salmeterolxinafoat / flutikasonpropionat - inhalasjonspulver, dosedispensert - 50 mikrog / 100 mikrog
salmeterol/fluticasone neutec 50 mikrog / 250 mikrog
neutec inhaler ireland limited - salmeterolxinafoat / flutikasonpropionat - inhalasjonspulver, dosedispensert - 50 mikrog / 250 mikrog
solifenacin sandoz 10 mg
sandoz - københavn - solifenacinsuksinat - tablett, filmdrasjert - 10 mg
solifenacin sandoz 5 mg
sandoz - københavn - solifenacinsuksinat - tablett, filmdrasjert - 5 mg
lilinorm 5 mg
ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 5 mg
lilinorm 5 mg / 10 mg
ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 5 mg / 10 mg
lilinorm 1 mg
ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 1 mg
onglyza
astrazeneca ab - saxagliptin - diabetes mellitus, type 2 - legemidler som brukes i diabetes - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
entocort 2 mg/100 ml
tillotts pharma gmbh - budesonid - tablett og væske til rektalvæske, suspensjon - 2 mg/100 ml
urizia 6 mg / 0.4 mg
astellas pharma a/s - solifenacinsuksinat / tamsulosinhydroklorid - tablett med modifisert frisetting - 6 mg / 0.4 mg